Financial insights of XXII

MyFinsight

For the quarter ending 2026-03-31, XXII made $4,105K in revenue. -$10,766K in net income. Net profit margin of -262.27%.

Income Statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Revenues, net	4,105	3,537	4,011	4,083
Cost of goods sold	1,925	2,056*	2,557	2,863
Excise taxes and fees on products	2,816	2,315*	2,513	1,855
Gross loss	-636	-834	-1,059	-635
Sales, general and administrative	2,118	1,824	1,849	2,119
Research and development	285	106	193	227
Other operating expense, net	-	-39	-111	-
Total operating expenses	2,403	1,969	2,153	2,346
Operating loss from continuing operations	-3,039	-2,803	-3,212	-2,981
Other income (expense), net	-	0	-33	-12
Interest income	31	37	16	14
Interest expense	11	12	534	351
Total other income (expense), net	20	25	-551	-349
Loss from continuing operations before income taxes	-3,019	-2,778	-3,763	-3,330
(benefit) provision for income taxes	-	6	-	-34
Net loss from continuing operations	-3,019	-2,784	-3,763	-3,296
Operating income from discontinued operations	-	-23	-	-
Interest expense	-	423	-	-
Total other expense	-	-1	-	-
Gain from discontinued operations before income taxes	-242	-24	9,252	-111
Net gain from discontinued operations	-242	-24	9,252	-111
Net loss	-3,261	-2,808	5,489	-3,407
Deemed dividends	589	4,679	-	-
Dividend for redemption of series a convertible preferred stock	6,916	-	-	-
Net loss available to common shareholders	-10,766	-7,487	5,489	-3,407

Basic EPS	-18.08	-40.675	1.55	-13.61
Diluted EPS	-18.08	-40.675	-0.28	-13.61
Basic Average Shares	595,344	184,067*	3,541,337	250,368
Diluted Average Shares	595,344	184,067*	11,888,488	250,368

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.